•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Several executives of Imexpharm Joint Stock Company (IMP, HoSE) reported selling shares in block trades in the May 7 session, reducing their respective holdings in the pharmaceutical company.
Tran Thi Dao, a member of the Board of Directors and Imexpharm’s Chief Executive Officer, sold 371,400 IMP shares via a block trade on May 7. After the transaction, her stake decreased from 671,400 shares (about 0.44% of charter capital) to 300,000 shares (about 0.2%).
Ngo Minh Tuan, Deputy CEO of Imexpharm, sold 156,000 IMP shares in the same May 7 block trade, reducing his ownership to 150,000 shares, about 0.1% of charter capital.
Huynh Van Nhung, another Deputy CEO, sold 80,000 IMP shares on May 7, bringing his holding down to 100,000 shares (about 0.065% of charter capital).
Dương Hoàng Vũ, Chief Financial Officer, sold 12,000 IMP shares, reducing his stake to 10,000 shares (about 0.006%).
The leadership’s share sales come as Imexpharm has undergone a change of ownership. Lian SGP Holding Pte. Ltd. reported acquiring 104.5 million IMP shares, increasing its ownership from 0% to 67.87% of charter capital and becoming the parent company of Imexpharm.
At a bid price of VND 57,400 per share, Lian SGP Holding Pte. Ltd. is estimated to have spent nearly VND 6,000 billion to complete the transaction.
Lian SGP Holding Pte. Ltd. is an indirect subsidiary owned by Livzon Pharmaceutical Group (China). Livzon, founded in 1985, has charter capital above CNY 935 million. The group researches, produces, and develops medicines, generics, traditional Chinese medicine, and ingredients, operating in more than 30 countries, including the US, EU, Korea, Japan, and Southeast Asia. Livzon is among the world’s top 25 pharmaceutical companies.
Lian SGP Holding Pte. Ltd. acquired Imexpharm from SK Group. In the deal, SK Investment Vina III Pte. Ltd. sold 68.8 million shares, expected to reduce its holding from 47.69% to 4.6 million shares (about 3%). Bình Minh Kim Investment Joint Stock Company sold all 15.02 million IMP shares, and KBA Investment Co. sold all 11.3 million IMP shares, leaving none of their IMP holdings.
SK Group transactions took place between April 17–21, 2026.
Premium gym chains are entering a “golden era” that is ending or already in decline, as rising operating costs collide with shifting consumer preferences toward more flexible, community-based ways to exercise. Long-term memberships are shrinking, margins are pressured by higher rents and facility expenses, and competition from smaller, more personalized…
